Tips For Healthcare M&A Amid Heightened Antitrust Scrutiny
The issuance of the 2023 Merger Guidelines,[1] coupled with recent policy statements by the Federal Trade Commission and the U.S. Department of Justice, Antitrust Division promise increasingly rigorous reviews of healthcare...To view the full article, register now.
Already a subscriber? Click here to view full article